Compare ESE & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESE | CAI |
|---|---|---|
| Founded | 1990 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.2B |
| IPO Year | 1994 | 2025 |
| Metric | ESE | CAI |
|---|---|---|
| Price | $263.27 | $29.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $283.33 | $30.91 |
| AVG Volume (30 Days) | 176.2K | ★ 4.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.10% | N/A |
| EPS Growth | ★ 193.15 | 69.79 |
| EPS | ★ 3.71 | N/A |
| Revenue | $37,000,000.00 | ★ $812,033,000.00 |
| Revenue This Year | $21.42 | $25.24 |
| Revenue Next Year | $6.99 | $22.32 |
| P/E Ratio | $70.12 | ★ N/A |
| Revenue Growth | N/A | ★ 96.97 |
| 52 Week Low | $193.68 | $14.19 |
| 52 Week High | $362.15 | $33.66 |
| Indicator | ESE | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 34.76 | 70.98 |
| Support Level | $260.73 | $17.15 |
| Resistance Level | $290.82 | N/A |
| Average True Range (ATR) | 7.31 | 1.41 |
| MACD | 0.35 | 0.33 |
| Stochastic Oscillator | 29.70 | 83.09 |
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test & Measurement (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.